XP Forte has a network of regulatory professionals
with its core team having over 70 years of regulatory experience across therapeutic areas. They have expertise in devising global drug development strategies, Drug Development, Orphan designations, Paediatrics (PIPs), ATMPs, oral hearings, Medical Device and global submissions: MAAs, BLAs, Canada, Japan, Latin America and Middle East & Africa (translations and Q&A). Furthermore they excel at Life Cycle Development, Therapeutic areas.
Extensive involvement in Patient Advocacy working on expert panels on patient ethics and access.
They are considered the place to go for regulatory problem-solving commercial supply.
Company Details
- Founded
- 2020
- Address
- 71-75 Shelton Street, London,england Wc2h 9jq,united Kingdom
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://xpforte.com
- HQ
- London, England
Xp Forte Regulatory Limited Questions
Xp Forte Regulatory Limited's website is http://xpforte.com
Xp Forte Regulatory Limited's LinkedIn profile is https://uk.linkedin.com/company/xpforte
Xp Forte Regulatory Limited's industry is
Pharmaceutical Manufacturing
Xp Forte Regulatory Limited's top competitors are
Biosergen,
Reloshare,
Sun Home,
1medical,
Farm's Elite,
Diurnal,
Thebestreputation,
Vasodynamics Ltd,
Chugai Pharma Europe,
Abs Staffing Solutions.
Xp Forte Regulatory Limited's categories are Pharmaceutical Manufacturing
Xp Forte Regulatory Limited's founding year is 2020
